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Research
AbstrACt
Objectives Digital interventions can change patients’ 
experiences of managing their health, either creating 
additional burden or improving their experience of 
healthcare. This qualitative study aimed to explore 
perceived burdens and benefits for patients using a 
digital self-management intervention for reducing high 
blood pressure. A secondary aim was to further our 
understanding of how best to capture burdens and 
benefits when evaluating health interventions.
Design Inductive qualitative process study nested in a 
randomised controlled trial.
setting Primary Care in the UK.
Participants 35 participants taking antihypertensive 
medication and with uncontrolled blood pressure at 
baseline participated in semistructured telephone 
interviews.
Intervention Digital self-management intervention to 
support blood pressure self-monitoring and medication 
change when recommended by the healthcare 
professional.
Analysis Data were analysed using inductive thematic 
analysis with techniques from grounded theory.
results Seven themes were developed which reflected 
perceived burdens and benefits of using the intervention, 
including worry about health, uncertainty about self-
monitoring and reassurance. The analysis showed how 
beliefs about their condition and treatment appeared 
to influence participants’ appraisal of the value of the 
intervention. This suggested that considering illness and 
treatment perceptions in Burden of Treatment theory could 
further our understanding of how individuals appraise the 
personal costs and benefits of self-managing their health.
Conclusions Patients’ appraisal of the burden or benefit 
of using a complex self-management intervention seemed 
to be influenced by experiences within the intervention 
(such as perceived availability of support) and beliefs 
about their condition and treatment (such as perceived 
control and risk of side effects). Developing our ability to 
adequately capture these salient burdens and benefits 
for patients could help enhance evaluation of self-
management interventions in the future. Many participants 
perceived important benefits from using the intervention, 
highlighting the need for theory to recognise that engaging 
in self-management can include positive as well as 
negative aspects.
trial registration number ISRCTN13790648; Pre-results.
bACkgrOunD
The work involved in looking after one’s 
health when living with a chronic condition 
can include complex tasks such as organ-
ising and adhering to treatment regimens, 
interacting with healthcare professionals 
(HCP), regular monitoring of health indica-
tors and making health-related decisions, all 
of which can accumulate into a considerable 
burden.1 Digital self-management interven-
tions are often developed to improve health 
outcomes, but these interventions could also 
either increase or minimise the burden of 
the healthcare process for patients. Devel-
oping our understanding of the burdens of 
self-management can help to better optimise 
the delivery of healthcare to improve adher-
ence and well-being.1–3 Burden of Treatment 
strengths and limitations of this study
 ► The exploratory, open approach to data collection 
enabled us to capture whichever benefits or burdens 
were most salient to the participants.
 ► We only interviewed participants at one point in 
time, so we were unable to gain an understanding of 
dynamic changes in perceived benefits or burdens 
over time.
 ► Both well and poorly controlled hypertensive pa-
tients took part in the interviews, but it was difficult 
to recruit low users of the intervention which could 
limit the generalisability of the findings.
 ► The asymptomatic nature of hypertension and the 
unique medication change pathway means that 
these findings may not be generalisable across 
conditions.
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(BoT) theory provides a mechanism for understanding 
these experiences in the context of patients’ personal 
capacity to cope, with emphasis on the role of wider 
healthcare systems and social networks available to the 
patient.1 
Health economic evaluations also focus on under-
standing the impact of healthcare on patients, seeking to 
weigh up the resources used against the health outcomes 
in order to better inform decision-making. Recent guide-
lines for economic evaluations in health and medicine 
recommend adopting a societal perspective such that all 
relevant outcomes are evaluated, rather than focusing 
only on formal healthcare costs.4 In particular, personal 
costs such as time spent in self-care should be included. 
Consequently, BoT theory and health economic evalua-
tions share an interest in adequately capturing the wider 
burdens or personal costs of engaging with healthcare. 
For consistency in terminology in this paper, negative 
outcomes/personal costs of healthcare will be referred to 
as ‘burdens’.
BoT theory considers patients’ time as a resource that 
is used by the healthcare system, while health economic 
evaluation counts time as an ‘opportunity cost’ where 
the patient ‘spends’ time that could have been spent on 
something other than healthcare. However, subjective 
experiences of time spent on digital interventions may be 
varied and complex. Heterogeneity in the relative value 
placed on the outcomes of the intervention5 may mean 
that for some participants the time spent engaging with 
elements of an intervention is not perceived as a burden 
but rather as a benefit, either because it is interesting, 
pleasant or meaningful in and of itself or because of the 
positive outcomes it can lead to. In other words, some 
people may actually like engaging with healthcare. The 
value of exploring the personal benefits of intervention 
participation has not received as much focus as under-
standing the costs, such as treatment burden. McNamee 
et al6 proposed that the health research guidelines for 
economic analysis may need to be adjusted for digital 
health interventions to ensure we can fully capture the 
heterogeneous costs and benefits arising when complex 
interventions are implemented in complex systems.
To further our understanding of how patients perceive 
benefits and burdens when using digital health inter-
ventions, we carried out a qualitative process study.7 
The digital Home and Online Management and Evalu-
ation of Blood Pressure (HOME BP) intervention was 
developed based on best practice recommendations to 
help improve hypertension in poorly controlled patients 
by facilitating self-monitoring of blood pressure (BP) 
at home and prompting appropriate intensification 
of medication by HCPs.8 This intervention could help 
minimise the treatment burden of hypertension by 
providing an online healthcare system in which HCPs 
have sight of patients’ home readings, streamlining the 
process for finding the most effective medication without 
the need for attending the general practitioner (GP) 
surgery. However, HOME BP is a complex, interactive 
multicomponent intervention, which creates potential 
diversity in the perceived burden and benefits for partic-
ipants using it. The contexts in which the intervention 
is embedded may also be diverse, and factors such as 
individual differences in patients’ health status, beliefs 
about medication and risks of high BP, availability of time 
and resources, and access to support may influence how 
the intervention is perceived and valued. The HOME 
BP intervention was developed using the person-based 
approach9 which emphasises the importance of under-
standing participants’ unique perspectives and different 
situations when developing and implementing digital 
interventions. Adopting a more granular approach to the 
evaluation of benefit and burden is consistent with the 
person-based approach, and with the BoT approach of 
fully understanding the participants’ perspective.
The present study aimed to explore the perceived 
burden and benefits of using a digital health intervention 
for self-managing BP using qualitative process interviews 
with intervention and usual care participants taking part 
in a randomised controlled trial (RCT). This paper seeks 
to interpret the implications for optimising the capture 
of perceived costs and benefits in health economic evalu-
ations and evaluating the burden of treatment.
MethODs
Design
A qualitative process study embedded in the HOME BP 
trial8 was approved by the University of Southampton and 
NHS Research Ethics committees. The COREQ checklist 
(Consolidated criteria for reporting qualitative studies) 
was used to ensure comprehensive reporting of the 
study10 (online supplementary file 1).
Intervention
The HOME BP programme supported participants to 
self-manage their high BP, primarily via home self-moni-
toring of BP and making changes to dose/drug type when 
recommended by the HCP. Lifestyle change modules were 
also available, but optional as the key target behaviours 
for the intervention were self-monitoring and medica-
tion change adherence.8 11 Participants using HOME BP 
were supported by a ‘prescriber’ (GP or nurse prescriber 
responsible for changing medication) and a ‘supporter’ 
(nurse or healthcare assistant who supported participants 
in self-monitoring and choosing lifestyle changes).
Participants were invited to use the online programme 
by their GP and were randomised to usual care or inter-
vention after completing baseline measures online. 
Those randomised to the intervention group completed 
two online training sessions which sought to overcome 
concerns about variability in readings and changing medi-
cation. Participants were encouraged to monitor their BP 
in the mornings, but the programme allowed flexibility 
as it was most important that people found a time of day 
that suited them to monitor their BP. Both intervention 
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and usual care participants were followed up at 6 and 12 
months after randomisation.
Table 1 describes the HOME BP intervention in more 
detail.
Participants
Patients were eligible to take part in the HOME BP trial if 
they had uncontrolled hypertension managed in Primary 
Care (mean BP reading of 140/90 mm Hg or more at base-
line taken at the GP surgery using a validated electronic 
automated sphygmomanometer (BP TRU BPM-200)). 
In addition, they needed to be prescribed one to three 
antihypertensive medications at baseline, and aged over 
18 (full inclusion and exclusion criteria are listed in the 
protocol8).
Both intervention and usual care participants were 
invited to take part in interviews as we felt that obtaining 
an understanding of managing BP in usual care would 
aid interpretation of the perceived burden and benefits 
of the intervention. We aimed to speak to participants at 
a range of time-points during the 12-month trial from 10 
weeks onwards as this gave participants the opportunity 
to become familiar with HOME BP. No new intervention 
content was introduced after the lifestyle sessions became 
available at 9 weeks.
recruitment and interview procedure
A subsample of RCT participants were invited by email to 
provide feedback on their experiences of managing their 
BP (n=78 of 622 patients in the RCT). Informed consent 
was taken by post or online, depending on participant 
preference. Recruitment was initially opportunistic, but 
subsequently a purposive approach was adopted to target 
younger participants, low engagers and those with recent 
uncontrolled self-monitored BP readings, informed by 
the concurrent analysis. Recruitment was stopped once 
the researchers agreed that data saturation had been 
reached and no new burdens or benefits were arising.
Semistructured interview schedules were codeveloped 
by experts in health psychology (KM, KB, RJB, LY, LD), 
health economics (JR) and sociology (CM). Open, induc-
tive questions were carefully selected to elicit data about 
the burden and benefits of BP management perceived as 
most salient by the participants (see online supplemen-
tary file 2 for interview schedules). The interviews were 
conducted by telephone to minimise the burden on 
participants, except in one case where the participant 
asked to meet face-to-face due to struggling with hearing 
on the telephone. The interviews took place between 
February 2016 and February 2017. Each participant was 
given a £10 gift voucher to thank them for their time.
All interviews were conducted by KM (MSc, BSc termed 
‘the researcher’), a female PhD candidate in Health 
Psychology who was also employed as a research assistant. 
Each interview was audio-recorded, and the researcher 
also took notes and completed a self-reflection log after-
wards to record any emerging thoughts on the data. 
Audio-recordings were transcribed verbatim and checked 
thoroughly by the researcher.
Patient and public involvement
Patient and public involvement (PPI) representatives 
have been involved in the design and conduct of the RCT, 
including decisions about recruitment processes, outcome 
measures and trial procedures. We also discussed the 
findings of this qualitative process study with our PPI to 
facilitate our interpretations of the data. The participants 
in the study were patients, ensuring we were collecting 
experiences of burden from the target population, and 
the results were fed back to the study participants as a 
newsletter.
Analysis
The analysis was an iterative process led by KM, supported 
by frequent discussion of emerging themes with LY and LD 
(who have extensive experience in qualitative research) 
Table 1 HOME BP intervention characteristics
Target behaviour Description
Self-monitoring BP Participants monitored their BP at home for 7 days every 4 weeks. After 7 days, they entered 
their BP readings on the HOME BP website and received instant automated feedback using a 
traffic light system. If BP was very high (red) or very low (blue), they were told to contact their 
GP surgery. If BP was above target (amber), they were told their prescriber would contact them 
about a medication change. If BP was on target (green), they were congratulated and asked to 
monitor their BP again next time.
Medication change The prescriber planned three potential medication changes with the participant at the start 
of the study. HOME BP informed prescribers by email when a patient’s home BP readings 
were above target and they could implement a preplanned change without needing to see the 
participant for an appointment.
Optional lifestyle changes At 9 weeks after randomisation, participants had the option of choosing an online session 
to support lifestyle change to help control their BP, specifically weight management, salt 
reduction, healthy diet, physical activity or alcohol reduction. Participants were alerted by email 
when this became available, and saw an option to view the healthy lifestyles session each time 
they logged on to HOME BP. The online lifestyle change sessions could be started at any time 
during the 12-month trial, from 9 weeks.
BP, blood pressure; GP, general practitioner; HOME BP, Home and Online Management and Evaluation of Blood Pressure.
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along with input regarding health economic and socio-
logical perspectives (JR and CM). Inductive thematic 
analysis methods were used12 13 with techniques from 
grounded theory such as memoing, constant comparison 
and diagramming to enhance our understanding and 
facilitate the development of higher themes.14 15 Data 
collection and analysis ran concurrently to enable purpo-
sive sampling based on analytic insights. Thorough line-
by-line coding was undertaken in NVivo V.10, 2017, and 
a coding manual was developed which evolved as more 
data were collected and coded. The emerging codes were 
constantly checked against the raw data to ensure the 
analysis was driven by the participants’ own language and 
experiences.
All data relating to burdens and benefits of managing 
BP were analysed. We also coded factors that appeared to 
influence perceptions of burdens and benefits to facilitate 
an in-depth understanding of how participants appraised 
the intervention’s value. A broad and open definition was 
adopted where benefits and burdens were defined as posi-
tive and negative outcomes or experiences of engaging in 
the intervention,16 in order to facilitate a comprehensive 
representation of all potentially relevant data.
results
Participant characteristics
In the intervention group, 28 of 54 invited participants 
agreed to be interviewed (52%). In the usual care group, 
7 of 24 invited participants agreed (29%). Most partici-
pants who did not take part chose not to reply, but those 
who did said they did not have anything to report on the 
trial (n=3 in usual care). The participants were from 19 
different GP surgeries. Table 2 shows the sociodemo-
graphic and intervention details of the sample.
themes
Table 3 presents seven themes exploring perceived 
burdens and benefits of the HOME BP intervention. 
One metatheme also emerged concerning how illness 
and treatment beliefs about high BP appeared to influ-
ence participants’ perceptions about the intervention’s 
burdens and benefits, and this is discussed in relation to 
each theme it applies to. Figure 1 shows how illness and 
treatment perceptions about BP appeared to relate to the 
subthemes identified by the thematic analysis.
Where quotes are included, participants are referred to 
as ‘p’ followed by a number. Study group (intervention or 
usual care) is also included to help understand the quotes 
in context.
Benefit of reassurance from seeing BP readings
Reassurance when BP readings are well controlled
Seeing well-controlled readings when self-monitoring BP 
gave participants peace of mind which was widely perceived 
as a benefit of the intervention. People described feeling 
relieved that their BP readings were lower than at the GP 
surgery, and felt this gave them more insights into what 
their BP was like most of the time.
What I do like about it is taking the blood pressure 
here at home, the readings are lower. And I find that 
quite reassuring that my blood pressure is not always 
high. (Intervention p11, well controlled)
Several usual care participants had decided to use their 
own BP monitors, and this group also described feeling 
reassurance when seeing their BP was well controlled.
Reassurance from keeping an eye on BP
Most participants liked having an increased focus on their 
BP through regular monitoring and found it interesting 
Table 2 Sociodemographic and intervention participant 
data (n=35)
Intervention 
participants
Usual care 
participants
n 28 7
Median duration of 
interview (range)
38 (15–67) min 28 (22–40) min
Median age (range) 70 (41–87) years 67 (52–77) years
Gender 71% female 43% female
Ethnicity
  White 24 6
  Black African 1
  Pakistani 1
  Other 2 1
Education levels 9 No formal 
education
2 No formal 
education
8 GCSE or A level 3 GCSE or A level
10 Higher 
education
1 Higher education
1 Other 1 Other
Median number 
of weeks into the 
study at which 
the interview took 
place (range)
20 (10–57) weeks 17 (7–24) weeks
Poorly controlled 
BP at the time of 
the interview
10/28 (36%) NA*
Medication change 
recommended 
during the study
15/28 (54%) NA
Accessed optional 
healthy lifestyles 
session
15/28 (54%) NA
*As BP self-monitoring was a key component of the intervention, 
BP readings were available for the intervention group throughout 
the duration of the study but data about BP from the usual care 
group were only available at RCT baseline and follow-up points.
BP, blood pressure; GCSE, General Certificate of Secondary 
Education; NA, not applicable; RCT, randomised controlled trial. 
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to compare their readings over time. However, one partic-
ipant perceived that taking BP regularly could encourage 
too much attention on your health, which was a poten-
tial burden of the intervention for her (Intervention 
p28, BP control unknown as did not enter BP readings 
on HOME BP). This participant had low concern about 
her BP generally, and was not motivated to engage in 
self-management.
Even when participants had poorly controlled read-
ings, many felt a benefit from the intervention as it 
enabled them to regularly check their BP and detect 
any problems instantly rather than carrying on unaware.
I think it’s helping me to know where my blood pres-
sure stands because it’s a regular thing every month. 
(Intervention p24, poorly controlled)
The knowledge that home readings were shared with 
the prescriber reassured participants as they knew that 
any problems would be detected and dealt with at the 
time, making them feel well cared for. This contrasted 
with the perceived burden of managing BP in usual care 
where some participants felt concerned that their GP did 
not change their medication when their home readings 
were too high, or would have liked more regular contact 
with their GP surgery to check their BP and medication.
Table 3 Themes and subthemes relating to perceived burdens and benefits of the intervention
Themes Subthemes Exemplar participant quote
Benefit of reassurance from 
seeing BP readings
Reassurance when BP 
readings are well controlled
‘I’m so pleased. And my mind is at rest when we go on holidays 
and all that…I’m alright. I’m alright sort of thing. Yeah, peace of 
mind.’ (Intervention p9, well controlled)
Reassurance from keeping 
an eye on BP
‘It made me much more aware of what the problem is with the 
high blood pressure and by monitoring it so regularly, I know 
exactly where I stand with it.’ (Intervention p15, well controlled)
Benefit of motivation for 
lifestyle change from seeing 
BP readings
Seeing BP readings 
motivated lifestyle change
‘It is quite interesting to see the effects of what I’m doing on 
the blood pressure and everything. So, I think that is—it is quite 
good.’ (Intervention p18, well controlled)
Benefit of better health Perceived health 
improvements from 
medication changes
‘It helped me to change my medication and then because 
of change of medication, my blood pressure went down. So 
definitely there is a benefit.’ (Intervention p16, well controlled)
Intervention can facilitate 
management of side effects
‘That medication didn’t work, in that I was on holiday and 
my ankles swelled up so much—and my feet and my legs, 
so much so that I couldn’t see my toes. So I stopped taking 
that medication. Was called back to the GP. And I’m now on 
a medication that works for me and is managing the blood 
pressure.’ (Intervention p7, well controlled)
Burden of worrying about 
health
Negative emotional 
responses to seeing high 
readings
‘I was actually quite shocked because it was a—a lot higher.’ 
(Intervention p6, poorly controlled)
Worrying about medication 
change affecting health
‘I don’t want to get more medication ‘cause I’m already on a high 
dose and I don’t want to increase it because it worries me about 
my kidneys.’ (Intervention p24, poorly controlled)
Burden of uncertainty from 
self-monitoring
Uncertainty about whether 
readings are representative
‘If someone only ever takes it in the morning, and you tend to get 
those lower readings, are you really getting a true picture of what 
they’re like in the afternoon or the evening?’ (Intervention p10, 
well controlled)
Uncertainty about what 
to do about high or low 
readings
‘I don’t know what’s going to happen in respect to that [amber 
feedback]. Whether I’m going to get a call from my GP, or whether 
he—so I’m a little bit, like, you know, in the air. I don’t really know 
what’s going to happen in that respect.’ (Intervention p22, poorly 
controlled)
Burden of thinking about 
making healthy lifestyle 
changes
Worry or guilt about not 
engaging with healthy 
changes
‘I have looked at it [online healthy lifestyles session]. I wouldn’t say 
I’ve looked at it seriously, and I need to.’ (Intervention p4, poorly 
controlled)
Burden of the practicalities 
of adhering to intervention 
procedures
Burden of fitting self-
monitoring into the day
‘I like to get up and have a cup of coffee and I’m thinking ‘Well, 
let’s get the blood pressure done first because otherwise I can’t 
do that, you know, for a while afterwards.’ So, I’ve found that 
quite—quite difficult.’ (Intervention p5, poorly controlled)
BP, blood pressure.
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It would be nice to have it checked, I guess, you 
know, every three months or whatever. How—howev-
er often. I mean, how do they know that everything is 
working? (Usual care p4)
This shows that although participants in usual care 
gained reassurance from seeing low readings when they 
monitored at home, the lack of interaction with the GP 
surgery could cause concern when readings were high or 
when patients did not regularly monitor BP at home of 
their own accord.
Benefit of motivation for lifestyle change from seeing BP readings
Some participants were motivated to increase their phys-
ical activity, engage in stress management activities or 
healthy eating because they could see this had a positive 
impact on their BP readings. This helped them feel more 
in control of their BP.
By taking the readings regularly and frequently, it 
gave me more of a feedback straightaway if you like 
about anything, changes that I did make like a bit of 
exercise or…practicing relaxation and this sort of 
Figure 1 Possible influences of illness and treatment beliefs on perceived burdens and benefits of the intervention. BP, blood 
pressure.
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thing. So that was quite nice, it was nice to feel that 
I was more in control of it again. (Intervention p20, 
well controlled)
Other participants felt frustrated after making life-
style changes in the past which had no effect on their 
BP. This made them feel that lifestyle was ineffective for 
controlling BP.
I’m a completely different person. My diet’s com-
pletely different. And my blood pressure remained 
the same. So I’ve done literally everything you phys-
ically possibly can to help yourself, and nothing’s 
worked. (Intervention p1, well controlled)
Benefit of better health
Perceived health improvements from medication changes
Many participants felt it was beneficial to change their 
medication when their readings were too high, and 
were very pleased when they perceived that a medica-
tion change led to lower BP readings because of the 
positive effect this would have on their health.
I’ve found that by having the medication changed up 
at regular intervals my blood pressure’s improved all 
the time. (Intervention p15, well controlled)
A few participants felt that a medication change had 
not been effective at lowering their BP which could 
create doubt about their medication’s effectiveness.
It’s been doubled but it hasn’t seemed to lower my 
blood pressure at all, in fact, it’s at the same levels 
as it is sort of now, un-medicated. So I just think—I 
don’t think it’s the right one. You know, I can take the 
tablet but, actually, I don’t think it’s doing anything. 
(Intervention p26, poorly controlled)
Intervention can facilitate management of side effects
Most participants did not experience any side effects from 
having their medication changed. Where side effects did 
occur, participants tended to perceive this as being a cost 
of taking medication (which was balanced against the 
benefit of controlling BP), rather than a burden of the 
intervention itself. They felt that the intervention could 
help them to be more aware of side effects, to identify 
alternative medications and to monitor how these affect 
their health.
That [side effect] would have happened, you know, 
no matter what. That would have been an issue but 
this has actually highlighted it, sort of, more clearly. 
(Intervention p5, poorly controlled)
Burden of worrying about health
Negative emotional responses to seeing high readings
A burden of self-monitoring BP for some people was that 
seeing high readings could cause worry about health. 
Participants’ beliefs about their BP control appeared 
to influence their appraisal of high readings. A few 
participants believed their BP was well controlled, a belief 
which was perhaps reinforced by clinical staff approving 
their readings previously, and had only joined the study 
to help with research. These participants tended to feel 
shocked or annoyed when they received above-target 
feedback from the intervention as this challenged their 
beliefs.
At one time, I was told to go on medication, further 
medication, which I must admit I was not very hap-
py about… When I used to go for a check with the 
nurse, if I’d have had those particular readings, they 
wouldn’t have been high. (Intervention p17, poorly 
controlled)
Others were confused or frustrated by high BP read-
ings when they could not understand why this might have 
happened.
I’m thinking about why my blood pressure has gone 
up. I can’t think why. (Intervention p25, poorly 
controlled)
Meanwhile, people who expected to see high readings 
were less concerned because they had accepted that high 
readings were likely.
Just par for the course. It’s what I expect from my 
blood pressure, really, so, it never worries me. 
(Intervention p5, poorly controlled)
Perceptions about the causes of high BP also influ-
enced how anxious people felt about seeing high read-
ings. Those who felt that high readings held serious 
implications for their health tended to feel frightened. 
Some even felt apprehensive before self-monitoring in case 
their readings were out of range, as they did not want to 
see evidence that their BP was too high or low.
Before I take my blood pressure, I do get stressed. I 
wouldn’t say I get massively stressed because obvious-
ly I’m used to doing it now but … it’s just that appre-
hension and thinking ‘Oh, God, I hope it’s not too 
high today.’ I wonder really what’s going on and how 
serious this is. (Intervention p26, poorly controlled)
Other people were able to dismiss one-off high read-
ings without feeling anxious as they attributed high 
readings to less threatening explanations such as feeling 
stressed, not sitting still for long enough, positioning of 
the cuff or held a prior expectation of it being normal for 
BP to fluctuate. In these cases, the high readings had less 
negative emotional impact as they were not interpreted as 
indicating a serious underlying health issue.
Worrying about medication change affecting health
Some participants were worried about the effects that 
changing BP medication could have on their health. 
Previous experience of side effects, existence of comor-
bidities and concerns about medication dependency or 
impact on kidneys tended to make participants feel more 
worried about changing medication.
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Perceptions about the health risk of high BP in terms 
of stroke and cardiovascular disease tended to affect 
how burdensome participants perceived a medication 
change to be. Anxiety about future health could over-ride 
concerns about medication side effects or dependency 
as the behaviour was evaluated as beneficial in order to 
bring BP down, although sometimes participants still 
experienced conflict between the perceived benefit and 
burden.
The blood pressure has gone down but now my 
worries have changed from blood pressure to other 
things. One is actually depending on medicine whole 
of my life. And secondly impact of medicine on my 
body like kidneys. (Intervention p16, well controlled)
Burden of uncertainty from self-monitoring
Uncertainty about whether readings are representative
While some participants were confident making deci-
sions about when to monitor their BP, others were 
worried about whether their readings were represen-
tative, especially when BP was seen to vary at different 
times of day or after physical activity or drinking coffee. 
This could lead to doubt about the meaningfulness 
of self-monitoring and the recommendations of the 
intervention.
I wonder if maybe the time of day I’m doing it, may-
be my blood pressure’s always gonna be roughly that. 
And could it be different during the day, is the sort of 
thing that does play in my mind a bit. (Intervention 
p1, well controlled)
Uncertainty about what to do about high or low readings
Uncertainty could also become a burden after seeing an 
out-of-range BP reading, as the participant had to decide 
what to do next. This burden was removed when the 
prescriber provided quick, personalised feedback to the 
participant, but when they did not receive any contact 
from their prescriber or felt the prescriber was not avail-
able to provide support, this could create a feeling of 
doubt.
I suppose I knew there was nothing to worry about 
but it’s always a bit of a niggle in the back of your 
mind… even the days she’s [the nurse prescriber] 
at work I can’t ring her at work because she may be, 
you know, doing something else. (Intervention p21, 
well controlled)
Burden of thinking about making healthy lifestyle changes
Worry or guilt about not engaging with healthy changes
Several participants felt they would like to lose weight, eat 
more healthily or do more physical activities but lacked 
the motivation or self-efficacy to make these changes, 
especially if they had other comorbidities. This could 
create feelings of guilt or worry about their failure to 
make healthy changes, which was a burden of the inter-
vention for them.
I understand that, obviously, I need to get my 
blood pressure down because it is very dangerously 
high, but I just don’t know what to do about it, you 
know?… where I feel fatigued and worn out, I don’t 
feel well enough at the moment to do any exercise. 
(Intervention p26, poorly controlled)
Burden of the practicalities of adhering to intervention procedures
Burden of fitting self-monitoring into the day
Many participants felt that self-monitoring was easy to fit 
into their day, and some described this as being easier 
than going to the GP surgery to have their BP taken. 
Those with busy daily lifestyles tended to find it harder to 
remember to self-monitor, and a burden for some partic-
ipants was deciding how best to fit self-monitoring into 
their routine given the instructions about not drinking 
coffee or exercising beforehand.
The perceived burden of regular self-monitoring 
seemed to be mitigated by the perceived benefit of the 
behaviour, such that those who felt reassurance from 
seeing low readings or with high motivation to control 
BP found it less hassle and easier to remember than those 
who felt anxious about self-monitoring or had only joined 
the study to help with research.
There was no big deal. It doesn’t take long and it’s—
it’s quite nice to sit down and have a relax during the 
day. (Intervention p8, well controlled)
DIsCussIOn
This qualitative study has identified diverse perceived 
burdens and benefits of using a self-management digital 
intervention for high BP. In support of the BoT theory,1 
the HOME BP intervention appeared to reduce the 
burden on patients to self-manage their condition by 
improving access to regular HCP support and facili-
tating better understanding of their condition, but in 
some cases there was a burden of worry about health 
or changing medication. How much benefit a patient 
perceived from the intervention compared with burden 
seemed to be influenced by the dynamics of the patient–
HCP interaction (described as ‘Improving Coopera-
tion’ in BoT theory) and the patient’s own resources 
to manage their condition and cope with medication 
(described as ‘Capacity’).
Another important factor relating to the burden 
experienced was personal beliefs about BP and treat-
ment. Those who recognised that their BP was too high 
and did not have concerns about side effects or taking 
medication appeared to have more positive experiences 
of the intervention, perceiving self-monitoring as more 
worthwhile and feeling less anxious about seeing high 
readings or changing medication. This is consistent with 
the necessity-concerns framework.17 BoT theory states 
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that people who are better equipped with resources 
and are more resilient may cope better with the burden 
imposed by healthcare,18 but the importance of an indi-
vidual’s personal conceptualisation of their condition 
in how burdensome they find self-care is not strongly 
represented. This beliefs system may be partly encom-
passed by the ‘Relational Integration’ aspect of BoT 
theory, which refers to the extent to which patients trust 
the tasks they do for healthcare (eg, self-monitoring 
BP), and feel confident in the outcomes of these tasks 
(eg, changing medication). However, illness and treat-
ment perceptions19 are not explicitly covered by the 
theory and it may be helpful to consider them as addi-
tional factors which might influence the experience of 
treatment burden.
Implications for measurement of benefit and burden
The present study demonstrates the value of collecting 
in-depth qualitative data to develop a detailed under-
standing of the burden of treatment, and to discover 
perceptions specific to the context in which the inter-
vention was implemented. The important psychoso-
cial outcomes discovered using qualitative research can 
inform the selection or development of relevant quan-
titative measures to capture these factors in further 
evaluation.
Quantitative measures have been developed to 
appraise the structural aspects of burden of treat-
ment,20 21 but these are not intended to assess psychoso-
cial factors such as reassurance, anxiety or uncertainty 
which this study suggests can influence the extent to 
which using an intervention is experienced subjectively 
as a burden.
Future research could explore how best to capture 
the perceived burden or benefit of an intervention. One 
approach might be to simply ask participants to quantify 
the net subjective burden or benefit of interventions. 
However, it could be challenging for participants to 
weigh complex heterogeneous psychosocial outcomes 
against one another and decide overall whether an 
intervention was more burdensome or beneficial. 
Capturing the extent to which patients experience posi-
tive or negative psychosocial outcomes might better 
assess how beneficial or burdensome the intervention 
was perceived to be. Although this would not produce 
a single outcome measure, cost-consequence analysis 
can be used to inform decision-making when an inter-
vention has multiple relevant outcomes which cannot 
be aggregated into one value.22 Coast et al23 discuss 
whether a multidimensional approach is more informa-
tive for economic analysis or if a single aggregated value 
is more pragmatic.
Extending the evaluation of outcomes beyond health 
is in line with the capability approach,24 which focuses 
on broader aspects of subjective well-being which are 
not assessed by generic measures such as the EQ-5D (five 
items for assessing standardised health status).25 Tools 
used to capture perceived capability (such as the ICECAP, 
a capability measure for use in economic evaluation26 and 
ASCOT, a tool for evaluating social-care related quality 
of life)27 are gaining support as holistic measures of 
economic evaluation, but do not assess the more specific 
psychosocial burdens and benefits of healthcare raised 
by participants in this study. Process utility emphasises 
the need to quantitatively measure the value that people 
attach to healthcare delivery. This approach might be 
relevant for evaluating how much value people perceive 
in the process of using digital health interventions and 
the capability this achieves.28 It has been argued that 
process utility measures should also ask about the reasons 
behind patients’ valuations, to better inform the deci-
sion-maker.29 This would help capture the individual 
differences found in this study in how people appraise 
the personal value of a digital intervention, informed by 
their underlying illness and treatment beliefs.
strengths and limitations
A strength of the study was that we used relatively open 
questions formulated by a multidisciplinary team which 
enabled us to elicit and explore a wide range of perceived 
burdens and benefits, some of which were not antici-
pated at the outset of research. We are aware of the lead 
researcher’s potential influence on the data analysis, 
which we strived to minimise by transparent memoing 
of decisions and regular team meetings to discuss the 
emerging themes. Participants were sent newsletters to 
describe the findings of the study, but were not invited to 
provide feedback on the analysis.
We succeeded in speaking to well-controlled and poorly 
controlled hypertensive participants at different points in 
the intervention, and there was a wide range of demo-
graphics in terms of age, education level and gender in 
the sample. However, the uptake rate from those invited 
to interviews was not high, particularly in the usual care 
group. Perhaps unsurprisingly, it was difficult to recruit 
low engagers in the intervention group, which could have 
helped reach theoretical saturation. In terms of wider 
applicability, we are aware that these findings may not be 
generalisable across other health conditions, as the lack 
of symptoms in hypertension and the stepped pathway 
for changing medication are quite unique features of this 
condition.
Repeated interviews with the same participants may 
have offered more insights into the dynamic nature of 
perceived burdens and benefits over time, although 
more regular conversations about the target behaviour 
could have influenced participants’ BP management 
behaviour, therefore threatening the RCT conclusions. 
It has been noted that a key issue with process evalua-
tions of interventions is the tendency for intervention 
content and impact to change over time,7 such that 
deciding the optimal point to collect evaluation data is 
challenging.
Some of the burdens and benefits described by 
patients in this study were also found to a lesser extent 
in the qualitative development of the HOME BP 
 o
n
 23 January 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-020843 on 8 May 2018. Downloaded from 
10 Morton K, et al. BMJ Open 2018;8:e020843. doi:10.1136/bmjopen-2017-020843
Open Access 
intervention, such as reassurance from seeing well-con-
trolled readings, and some concerns about side effects 
and high or variable readings (Bradbury et al, Submis-
sion, 2017). Others were novel and only arose when 
participants experienced the full HOME BP interven-
tion during the RCT as opposed to a prototype, for 
example, the perceived health improvements from 
medication changes. This demonstrates the value of 
conducting inductive qualitative research to explore 
users’ perspectives at each stage of intervention devel-
opment and evaluation, in line with the person-based 
approach.9
COnClusIOns
In the context of this digital intervention, the study 
shows that participants’ appraisal of burdens and benefits 
appeared to be influenced by both intervention factors, 
such as BP readings and perceived availability of the HCP, 
and patient characteristics, such as perceptions of BP 
control, previous experience of side effects and comor-
bidities. This nuanced evaluation would be lost in a popu-
lation-level analysis, demonstrating the advantage of a 
more individualised approach for better understanding 
participants’ perspectives of an intervention and how best 
to minimise the burden of treatment.
The study develops the recommendations of McNamee 
et al6 that complex digital health interventions warrant a 
wider perspective for measuring health outcomes, and 
discusses the implications of capturing broader psychosocial 
outcomes for BoT theory and health economic evaluations.
The finding that some participants perceived personal 
benefits from using the intervention demonstrates that 
the process of healthcare can, in itself, be positive for 
some people, highlighting the importance of capturing 
transient short-term benefits to take these into account as 
well as the burden of self-management.
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